EQT Fund Management’s Evommune EVMN Stock Holding History
Bought
Maintained
Sold
Other funds holding EVMN
BBA
KCM
EQT Fund Management's EVMN Position: Q3 2026 in Review
EQT Fund Management held its Evommune (EVMN) position steady in Q3 2026 at 5,288,313 shares worth $43.7M. The position accounts for 4.61% of the portfolio, ranked #5.
EQT Fund Management first reported a position in EVMN in Q4 2025 and has held it in 4 quarters since. The position peaked at $113M in Q1 2026. 102 funds tracked by Wall St. Rank hold EVMN as of Q3 2026.
- EQT Fund Management held 5,288,313 shares of Evommune worth $43.7M as of Q3 2026.
- EQT Fund Management left its Evommune share count unchanged in Q3 2026.
- Evommune made up 4.61% of EQT Fund Management's portfolio in Q3 2026, its #5 holding.
- EQT Fund Management first reported a position in Evommune in Q4 2025 and has held it in 4 quarters since.
- EQT Fund Management's Evommune position peaked at $113M in Q1 2026.
- 102 funds tracked by Wall St. Rank held Evommune as of Q3 2026.
Based on EQT Fund Management's 13F filing for Q3 2026, filed 12 Nov 2026.